WisdomTree BioRevolution Fund (WDNA)
WisdomTree BioRevolution Fund operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $21.37, up 0.64% on the session, giving a market capitalisation of $2.8M. Its beta of 1.26 implies it has historically moved more than the broad market.
This fund primarily aims to meet its investment goals by employing a representative sampling method. This means it selects a portion of the securities from its benchmark index, ensuring that this smaller selection closely reflects the broader index's risk profile, expected returns, and other key characteristics. The benchmark index itself is crafted to invest in global, exchange-listed companies that are poised for significant transformation through breakthroughs in genetic research and biotechnology. It's important to note that this fund is categorized as non-diversified.
WisdomTree BioRevolution Fund is most often compared with the following Financial Services names: